Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Obesity Paradox: Does It Lengthen Survival in Iranian Covid Patients? Publisher



Khalooeifard R1 ; Hemmati A2 ; Izadi N3 ; Clark C4 ; Hashemian SMR5 ; Emam MH6 ; Moghaddam OM7 ; Amirsavadkouhi A5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Clinical Nutrition at Tehran University of Medical Sciences, Iran
  3. 3. Cancer Research Center, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Centre for Intelligent Healthcare, Coventry University, United Kingdom
  5. 5. Shahid Beheshti University of Medical Sciences, Iranian Critical Care Society, Behnam St, No. 1, Unit 15, Tehran, Iran
  6. 6. Iran University of Medical Sciences, Tehran, Iran
  7. 7. Trauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Nutrition Today Published:2022


Abstract

A prominent issue for patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is obesity. Some reports claim that obese patients with acute respiratory distress syndrome have better outcomes. This inverse relationship has been termed the obesity paradox and is not yet understood in patients with coronavirus disease 2019 (COVID-19) hospitalized in the intensive care unit (ICU). The aim of this study was to investigate the obesity paradox in patients with COVID-19 admitted to the ICU. In this retrospective observational study, 5230 patients with COVID-19, admitted to the ICU between June 1, 2020, and January 10, 2021, were analyzed. Body mass index (BMI) was calculated according to the World Health Organization classification, and patients were categorized as underweight, normal, overweight, or obese for statistical analysis. A Kaplan-Meier survival analysis, Cox regression model, and dose-response relationship between BMI level and ICU length of stay (LOS) and connection to the ventilator survival were conducted. Of the 5230 patients studied, 3233 (62%) had nonobese BMIs, and 2997 (38%) were obese. We found no significant difference in mortality between obese and nonobese patients with COVID-19, where 1699 patients (31%) survived. However, there were significant differences in BMI level for ICU LOS and ventilation duration (P < 0.05, P < 0.03). In multivariable Cox regression, significant differences were observed in ICU LOS and ventilation duration of patients between obese and nonobese patients (P < 0.001, P < 0.005). There was no association between BMI and survival among patients with LOS in the ICU LOS or connection to a ventilator. However, obese patients with COVID-19 require more care than nonobese patients because of additional comorbidities, higher inflammation, and a weaker immune system. © Wolters Kluwer Health, Inc. All rights reserved.
Related Docs
View other Related Docs
1. Obesity in Covid-19 Era, Implications for Mechanisms, Comorbidities, and Prognosis: A Review and Meta-Analysis, International Journal of Obesity (2021)
2. Evaluation of Relationship Between Risk Factors of Cardiovascular Disease and Morbidity and Mortality of Covid-19 Patients, Journal of Iranian Medical Council (2023)
3. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
4. The Association Between the Level of Serum 25(Oh) Vitamin D, Obesity, and Underlying Diseases With the Risk of Developing Covid-19 Infection: A Case–Control Study of Hospitalized Patients in Tehran, Iran, Journal of Medical Virology (2021)
5. Metabolic Syndrome and Covid-19; Clinical Complications and Challenges, Journal of Isfahan Medical School (2021)
6. The Association Between Obesity With Treatment Duration, Icu Length of Stay and the Risk of Death in Critically Ill Patients With Covid-19, Endocrinology# Diabetes and Metabolism (2023)
7. Covid-19 Infection in Heart Transplant Recipients: Results of a Six-Month Prospective Survey-Based Study, Acta Medica Iranica (2022)
8. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Kurosh Djafarian (2)
Other Related Docs
9. The Role of Bacterial and Fungal Human Respiratory Microbiota in Covid-19 Patients, BioMed Research International (2021)
10. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
11. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)
12. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
13. Covid-19 in Patients With Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization, Rheumatology and Therapy (2023)
14. The Relationship of Covid-19 Severity With Laboratory Findings and Neutrophil-To-Lymphocyte Ratio in Patients Admitted to a Large Teaching Hospital in Iran: A Cross-Sectional Study, Health Science Reports (2024)
15. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
16. The Effect of Body Mass Index on the Morbidity and Outcomes of Covid-19 in Iranian Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
17. Post-Exposure Prophylaxis for Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2023)
18. Serum C-Reactive Protein Greater Than 75 Mg/Dl As an Early Available Laboratory Predictor of Severe Covid-19: A Systematic Review, Immunity# Inflammation and Disease (2023)
19. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
20. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
21. Obesity As an Independent Risk Factor for Covid-19 Severity and Mortality, Cochrane Database of Systematic Reviews (2023)
22. The Negative Impact of Obesity on the Occurrence and Prognosis of the 2019 Novel Coronavirus (Covid-19) Disease: A Systematic Review and Meta-Analysis, Eating and Weight Disorders (2022)
23. Predictors of Mortality for Severe Covid-19: A Descriptive Analysis From an Intensive Care Unit of a Tertiary Care Center, Archives of Anesthesiology and Critical Care (2025)
24. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
25. Renal Cell Carcinoma Survival and Body Mass Index: A Dose-Response Meta-Analysis Reveals Another Potential Paradox Within a Paradox, International Journal of Obesity (2016)
26. Risk of Type 2 Diabetes in Metabolically Healthy People in Different Categories of Body Mass Index: An Updated Network Meta-Analysis of Prospective Cohort Studies, Journal of Cardiovascular and Thoracic Research (2019)
27. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
28. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
29. Nbs Superfood: A Promising Adjunctive Therapy in Critically Ill Icu Patients With Omicron Variant of Covid-19, AMB Express (2024)
30. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
31. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
32. Metabolic Risk Factors and Risk of Covid-19: A Systematic Review and Meta-Analysis, PLoS ONE (2020)
33. The Association of Ct-Measured Cardiac Indices With Lung Involvement and Clinical Outcome in Patients With Covid-19, Academic Radiology (2021)
34. Post-Discharge Thromboembolic Events in Covid-19 Patients: A Review on the Necessity for Prophylaxis, Clinical and Applied Thrombosis/Hemostasis (2023)
35. Bradykinin As a Probable Aspect in Sars-Cov-2 Scenarios: Is Bradykinin Sneaking Out of Our Sight?, Iranian Journal of Allergy# Asthma and Immunology (2020)
36. Association Between Cardiometabolic Risk Factors and Covid-19 Susceptibility, Severity and Mortality: A Review, Journal of Diabetes and Metabolic Disorders (2021)
37. Aging & Covid-19 Susceptibility, Disease Severity, and Clinical Outcomes: The Role of Entangled Risk Factors, Experimental Gerontology (2021)
38. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)
39. Dose-Response Meta-Analysis of the Impact of Body Mass Index on Mortality in the Intensive Care Unit, Nutrition in Clinical Practice (2020)
40. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
41. Clinical and Laboratory Characteristics of Patients With Hypertension Admitted to Baharloo Hospital in Tehran With a Diagnosis of Covid-19 and Its Association With Mortality in 2020, Journal of Knowledge and Health in Basic Medical Sciences (2021)
42. Evaluation of Blood Biochemistry and Cardiopulmonary Status of Hospitalized Covid-19 Patients in 3 Months Post Discharged Follow up Survey, Clinical Medicine Insights: Circulatory# Respiratory and Pulmonary Medicine (2022)
43. Review on Oxidative Stress Relation on Covid-19: Biomolecular and Bioanalytical Approach, International Journal of Biological Macromolecules (2021)
44. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
45. Relationship Between Physical Activity, Healthy Lifestyle and Covid-19 Disease Severity; a Cross-Sectional Study, Journal of Public Health (Germany) (2023)
46. Epicardial Adipose Tissue, Inflammatory Biomarkers and Covid-19: Is There a Possible Relationship?, International Immunopharmacology (2021)
47. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)